MicroRNA-200c/141 Cluster as a Control Switch Between Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Human Colorectal Cancer Metastasis

2011 ◽  
Vol 140 (5) ◽  
pp. S-817 ◽  
Author(s):  
Keun Hur ◽  
Masanobu Takahashi ◽  
Francesc Balaguer ◽  
Takeshi Nagasaka ◽  
Hiromichi Hemmi ◽  
...  
Gut ◽  
2012 ◽  
Vol 62 (9) ◽  
pp. 1315-1326 ◽  
Author(s):  
Keun Hur ◽  
Yuji Toiyama ◽  
Masanobu Takahashi ◽  
Francesc Balaguer ◽  
Takeshi Nagasaka ◽  
...  

2020 ◽  
Vol 21 (18) ◽  
pp. 6499
Author(s):  
Xiaojuan Zhao ◽  
Shuzhen Liu ◽  
Bianbian Yan ◽  
Jin Yang ◽  
Erfei Chen

Metastasis is a well-known poor prognostic factor and primary cause of mortality in patients with colorectal cancer (CRC). Recently, with the progress of high through-put sequencing, aberrantly expressed non-coding RNAs (ncRNAs) were found to participate in the initiation and development of cancer. However, the mechanisms of ncRNA-mediated regulation of metastasis in CRC remain largely unknown. In this study, we systematically analyzed the expression network of microRNAs (miRNAs) and genes in CRC metastasis using bioinformatics, and discovered that the miR-581/SMAD7 axis could be a potential factor that drives CRC metastasis. A dual luciferase report assay and protein analysis confirmed the binding relationship between miR-581 and SMAD7. Further functional assays revealed that miR-581 inhibition could suppress cell proliferation and induce apoptosis in SW480 cells. Up-regulation or down-regulation of miR-581 could both affect cell invasion capacity and modulate epithelial to mesenchymal transition (EMT) via a SMAD7/TGFβ signaling pathway. In conclusion, our findings elucidated that miR-581/SMAD7 could be essential for CRC metastasis, and may serve as a potential therapeutic target for CRC patients.


Theranostics ◽  
2020 ◽  
Vol 10 (16) ◽  
pp. 7083-7099 ◽  
Author(s):  
Chih-Jie Shen ◽  
Kwang-Yu Chang ◽  
Bo-Wen Lin ◽  
Wei-Ting Lin ◽  
Che-Min Su ◽  
...  

2021 ◽  
Author(s):  
Heyang Xu ◽  
Qiusheng Lan ◽  
Yongliang Huang ◽  
Yang Zhang ◽  
Yujie Zeng ◽  
...  

Abstract Background: Liver metastasis is the most common cause of death in patients with colorectal cancer (CRC). Phosphatase of regenerating liver-3 induces CRC metastasis by epithelial-to-mesenchymal transition, which promotes CRC cell liver metastasis. Mesenchymal-to-epithelial transition (MET), the opposite of epithelial-to-mesenchymal transition, has been proposed as a mechanism for the establishment of metastatic neoplasms. However, the molecular mechanism of MET remains unclear. Methods: Using Immunohistochemistry, western blotting,invasion assays, real-time quantitative PCR, chromatin immunoprecipitation, luciferase reporter assays, human miRNA arrays, and xenograft mouse model, we determined the role of hepatocyte exosome-derived miR-203a-3p in CRC MET.Results: In our study, we found that miR-203a-3p derived from hepatocyte exosomes increased colorectal cancer cells E-cadherin expression, inhibited Src expression, and reduced activity. In this way miR-203a-3p induced the decreased invasion rate of CRC cells.Coclusion: MiR-203a-3p derived from hepatocyte exosomes plays an important role of CRC cells to colonize in liver.


Sign in / Sign up

Export Citation Format

Share Document